Efficacy and safety of furmonertinib in patients with EGFR‑mutant advanced lung adenocarcinoma after failure of multiple lines of therapy: A single‑center retrospective study. - Zheng, Yumin; Lu, Xingyu; Dong, Huijing; Li, Jia; Shen, Yulei; Liu, Zhening; Cui, Huijuan (Oncology Letters, 2025)